Inventor · disambiguated record
Thomas E. Barta
Also filed as: BARTA THOMAS · BARTA THOMAS E
47 granted patents·26 pending applications·554 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
73 records- 0195US10980801B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2020·Granted Apr 20, 2021·6 cites·15 claims
- 0295US7678803B2Quinazoline derivatives for the treatment of cancerSERENEX INC·Filed 2007·Granted Mar 16, 2010·97 cites·46 claims
- 0394US10688114B2Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activitySRX CARDIO LLC·Filed 2019·Granted Jun 23, 2020·5 cites·15 claims
- 0493US5620999ABenzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammationFiled 1994·Granted Apr 15, 1997·57 cites·23 claims
- 0592US10865185B2Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Dec 15, 2020·5 cites·8 claims
- 0692US10568882B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2016·Granted Feb 25, 2020·6 cites·13 claims
- 0792US10287317B2Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levelsSRX CARDIO LLC·Filed 2015·Granted May 14, 2019·12 cites·28 claims
- 0892US7358370B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2006·Granted Apr 15, 2008·21 cites·30 claims
- 0992US5451679A2-chloro and 2-bromo derivatives of 1,5-iminosugarsSEARLE & CO·Filed 1994·Granted Sep 19, 1995·32 cites·33 claims
- 1091US7115632B1Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Oct 3, 2006·33 cites·55 claims
- 1189US10821106B2Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2016·Granted Nov 3, 2020·4 cites·11 claims
- 1289US10307433B2Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activitySRX CARDIO LLC·Filed 2018·Granted Jun 4, 2019·5 cites·20 claims
- 1388US10034892B2Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activitySRX CARDIO LLC·Filed 2015·Granted Jul 31, 2018·5 cites·24 claims
- 1488US7928135B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2010·Granted Apr 19, 2011·8 cites·4 claims
- 1588US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 1687US7906529B2Benzene, pyridine, and pyridazine derivativesSERENEX INC·Filed 2007·Granted Mar 15, 2011·7 cites·8 claims
- 1786US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 1886US6426360B14,5-substituted imidazolyl compounds for the treatment of inflammationSEARLE & CO·Filed 2000·Granted Jul 30, 2002·17 cites·28 claims
- 1985US2024122951A1Method to treat lipid dysregulation by modulating activity of proprotein convertase subtilisin/kexin type 9 (pcsk9) protein with small molecule ligandsSRX CARDIO LLC·Filed 2023·Application pending·0 cites
- 2082US7282506B22,8-disubstituted naphthyridine derivativesSERENEX INC·Filed 2005·Granted Oct 16, 2007·5 cites·19 claims
- 2181US6689794B2Aromatic sulfone hydroxamates and their use as protease inhibitorsPHARMACIA CORP·Filed 2002·Granted Feb 10, 2004·12 cites·90 claims
- 2280US5595981A2-chloro and 2-bromo derivatives of 1,5-iminosugarsSEARLE & CO·Filed 1995·Granted Jan 21, 1997·16 cites·2 claims
- 2380US2024415830A1Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activitySRX CARDIO LLC·Filed 2024·Application pending·0 cites
- 2479US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 2579US5663342A2-chloro and 2-bromo derivatives of 1,5-iminosugarsSEARLE & CO·Filed 1996·Granted Sep 2, 1997·15 cites·2 claims
- 2678US11771710B2Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligandsSRX CARDIO LLC·Filed 2021·Granted Oct 3, 2023·0 cites·13 claims
- 2777US6265439B1Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 2000·Granted Jul 24, 2001·7 cites·22 claims
- 2875US9656956B2Benzene, pyridine, and pyridazine derivativesESANEX INC·Filed 2014·Granted May 23, 2017·2 cites·9 claims
- 2974US6696449B2Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitorsPHARMACIA CORP·Filed 2001·Granted Feb 24, 2004·8 cites·39 claims
- 3074US5451604AHalogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressivesSEARLE & CO·Filed 1993·Granted Sep 19, 1995·11 cites·4 claims
- 3173US11026957B2Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligandsSRX CARDIO LLC·Filed 2020·Granted Jun 8, 2021·0 cites·15 claims
- 3273US6750233B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2001·Granted Jun 15, 2004·6 cites·103 claims
- 3372US5612480A2-chloro and 2-bromo derivatives of 1,5-iminosugarsSEARLE & CO·Filed 1995·Granted Mar 18, 1997·11 cites·8 claims
- 3471US6683078B2Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitorsPHARMACIA CORP·Filed 2002·Granted Jan 27, 2004·6 cites·37 claims
- 3570US11925637B2Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their useSRX CARDIO LLC·Filed 2021·Granted Mar 12, 2024·0 cites·17 claims
- 3670US6656954B2Sulfonyl divalent aryl or heteroaryl hydroxamic acid compoundsPHARMACIA CORP·Filed 2001·Granted Dec 2, 2003·3 cites·25 claims
- 3769US11944619B2Phenylalanine small organic compounds to directly modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2020·Granted Apr 2, 2024·0 cites·17 claims
- 3869US6890937B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2003·Granted May 10, 2005·4 cites·39 claims
- 3967US11945782B2Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activitySRX CARDIO LLC·Filed 2020·Granted Apr 2, 2024·0 cites·5 claims
- 4066US6794511B2Sulfonyl aryl or heteroaryl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Sep 21, 2004·2 cites·26 claims
- 4166US6541489B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorSEARLE & CO·Filed 1998·Granted Apr 1, 2003·21 cites·19 claims
- 4266US6476027B1N-hydroxy 4-sulfonyl butanamide compoundsMONSANTO CO·Filed 1998·Granted Nov 5, 2002·10 cites·47 claims
- 4365US6583299B1α-amino-β-sulfonyl hydroxamic acid compoundsSEARLE & CO·Filed 2000·Granted Jun 24, 2003·2 cites·68 claims
- 4465US2020071308A1Benzene, Pyridine, and Pyridazine DerivativesESANEX INC·Filed 2019·Application pending·0 cites
- 4563US11891369B2Compounds for binding proprotein convertase subtilisin/kexin type 9SRX CARDIO LLC·Filed 2020·Granted Feb 6, 2024·0 cites·5 claims
- 4659US6087359AThioaryl sulfonamide hydroxamic acid compoundsFiled 1998·Granted Jul 11, 2000·7 cites·19 claims
- 4759US2017260174A1Benzene, Pyridine, and Pyridazine DerivativesESANEX INC·Filed 2017·Application pending·0 cites
- 4858US2013137686A1Benzene, pyridine, and pyridazine derivativesESANEX INC·Filed 2012·Application pending·0 cites
- 4957US2005101641A1Aromatic sulfone hydroxamic acids and their use as protease inhibitorsFiled 2004·Application pending·0 cites
- 5056US6380258B2Sulfonyl divalent aryl or heteroaryl hydroxamic acid compoundsG D SEARLE L L C·Filed 1998·Granted Apr 30, 2002·13 cites·23 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →